ChemoMetec Logo

ChemoMetec

ISIN: DK0060055861 | Ticker: CHEMM | LEI: 213800533NBKECGONO68
Sector: Health CareSub-Industry: Health Care Equipment
Country: Denmark

About ChemoMetec

Company Description

ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments.

We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences.

Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship.

Year founded

1997

Served area

Worldwide

Headquarters

Gydevang 43, 3450 Allerod – Denmark

Financial statements

Download as Excel
Line item in (dkk) 02.07.2020 01.07.2021 02.07.2021 01.01.2022 01.07.2022 02.07.2022 01.01.2023 01.07.2023
Assets N/A 344,909,000.00 N/A 371,205,000.00 501,273,000.00 N/A 556,737,000.00 657,976,000.00
Noncurrent Assets N/A 100,552,000.00 N/A 132,645,000.00 148,338,000.00 N/A 158,435,000.00 165,315,000.00
Property Plant And Equipment N/A 42,496,000.00 N/A 69,781,000.00 74,783,000.00 N/A 84,036,000.00 82,685,000.00
Land And Buildings N/A 24,172,000.00 N/A 48,457,000.00 48,392,000.00 N/A 59,991,000.00 56,003,000.00
Machinery N/A 11,692,000.00 N/A 15,029,000.00 21,066,000.00 N/A 19,552,000.00 9,776,000.00
Construction In Progress N/A N/A N/A N/A 7,714,000.00 N/A N/A 13,537,000.00
Other Property Plant And Equipment N/A 6,632,000.00 N/A 6,295,000.00 5,326,000.00 N/A 4,492,000.00 3,369,000.00
Intangible Assets Other Than Goodwill N/A 57,884,000.00 N/A 62,566,000.00 67,398,000.00 N/A 74,076,000.00 79,663,000.00
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights N/A 2,269,000.00 N/A 2,100,000.00 1,928,000.00 N/A 1,821,000.00 1,755,000.00
Intangible Assets Under Development N/A 22,911,000.00 N/A 30,927,000.00 39,096,000.00 N/A 49,045,000.00 56,176,000.00
Deferred Tax Assets N/A N/A N/A N/A 5,854,000.00 N/A N/A 2,649,000.00
Current Tax Assets Noncurrent N/A N/A N/A N/A 5,854,000.00 N/A N/A N/A
Longterm Deposits N/A 172,000.00 N/A 298,000.00 303,000.00 N/A 323,000.00 318,000.00
Current Assets N/A 244,357,000.00 N/A 238,560,000.00 352,935,000.00 N/A 398,301,000.00 492,661,000.00
Inventories N/A 30,113,000.00 N/A 45,588,000.00 66,790,000.00 N/A 92,860,000.00 112,635,000.00
Other Current Receivables N/A 12,005,000.00 N/A 23,005,000.00 3,669,000.00 N/A 3,801,000.00 4,913,000.00
Cash and cash equivalents 96,941,000.00 150,109,000.00 150,109,000.00 114,732,000.00 209,025,000.00 209,025,000.00 224,422,000.00 316,571,000.00
Cash N/A 150,109,000.00 N/A 114,732,000.00 209,025,000.00 N/A 224,422,000.00 316,571,000.00
Equity And Liabilities N/A 344,909,000.00 N/A 371,205,000.00 501,273,000.00 N/A 556,737,000.00 657,976,000.00
Equity 202,751,000.00 264,977,000.00 264,977,000.00 282,609,000.00 357,205,000.00 357,205,000.00 457,190,000.00 533,042,000.00
Issued Capital N/A 17,402,000.00 N/A 17,402,000.00 17,402,000.00 N/A 17,402,000.00 17,402,000.00
Other Reserves N/A 247,575,000.00 N/A 265,207,000.00 339,803,000.00 N/A 439,788,000.00 515,640,000.00
Liabilities N/A 79,932,000.00 N/A 88,596,000.00 144,068,000.00 N/A 99,547,000.00 124,934,000.00
Noncurrent Liabilities N/A 7,959,000.00 N/A 11,146,000.00 6,690,000.00 N/A 7,821,000.00 5,743,000.00
Other Longterm Provisions N/A 1,290,000.00 N/A 1,390,000.00 1,830,000.00 N/A 2,030,000.00 2,100,000.00
Deferred Tax Liabilities N/A 5,757,000.00 N/A 6,333,000.00 N/A N/A 1,279,000.00 N/A
Current Liabilities N/A 71,973,000.00 N/A 77,450,000.00 137,378,000.00 N/A 91,726,000.00 119,191,000.00
Trade And Other Current Payables N/A 8,710,000.00 N/A 11,505,000.00 17,023,000.00 N/A 12,650,000.00 17,550,000.00
Current Tax Liabilities Current N/A 21,937,000.00 N/A 23,445,000.00 54,622,000.00 N/A 22,659,000.00 43,440,000.00
Other Current Liabilities N/A 21,246,000.00 N/A 14,696,000.00 30,176,000.00 N/A 11,902,000.00 8,204,000.00
Current Loans Received And Current Portion Of Noncurrent Loans Received N/A 592,000.00 N/A 713,000.00 1,025,000.00 N/A 941,000.00 1,011,000.00
Line item in (dkk) 01.07.2020/
01.07.2021
01.07.2021/
01.01.2022
01.07.2021/
01.07.2022
01.07.2022/
01.01.2023
01.07.2022/
01.07.2023
Revenue 281,127,000.00 209,807,000.00 427,160,000.00 240,603,000.00 442,274,000.00
Other Income N/A N/A 1,231,000.00 2,054,000.00 2,127,000.00
Other Work Performed By Entity And Capitalised 9,547,000.00 5,737,000.00 11,216,000.00 5,445,000.00 11,348,000.00
Raw Materials And Consumables Used 37,330,000.00 33,852,000.00 55,354,000.00 35,377,000.00 60,359,000.00
Employee Benefits Expense 94,273,000.00 47,728,000.00 120,060,000.00 45,384,000.00 99,644,000.00
Depreciation And Amortisation Expense 19,607,000.00 9,684,000.00 20,038,000.00 10,478,000.00 20,469,000.00
Other Expense By Nature 23,441,000.00 18,033,000.00 41,301,000.00 22,100,000.00 44,716,000.00
Profit Loss From Operating Activities 116,023,000.00 106,247,000.00 202,854,000.00 134,763,000.00 230,561,000.00
Finance Costs 4,210,000.00 775,000.00 1,518,000.00 851,000.00 2,717,000.00
Profit Loss Before Tax 112,733,000.00 109,134,000.00 203,220,000.00 135,949,000.00 230,360,000.00
Income Tax Expense Continuing Operations 24,379,000.00 23,949,000.00 43,751,000.00 30,526,000.00 51,693,000.00
Profit (loss) 88,354,000.00 85,185,000.00 159,469,000.00 105,423,000.00 178,667,000.00
Line item in (dkk) 01.07.2021 02.07.2020 01.01.2022 01.07.2022 02.07.2021 01.01.2023 01.07.2023 02.07.2022
Profit (loss) 88,354,000.00 N/A 85,185,000.00 159,469,000.00 N/A 105,423,000.00 178,667,000.00 N/A
Adjustments For Depreciation And Amortisation Expense 19,607,000.00 N/A 9,684,000.00 20,038,000.00 N/A 10,478,000.00 20,469,000.00 N/A
Interest Paid Classified As Operating Activities 918,000.00 N/A 775,000.00 1,518,000.00 N/A 634,000.00 1,093,000.00 N/A
Interest Received Classified As Operating Activities 88,000.00 N/A 1,000.00 9,000.00 N/A 217,000.00 2,457,000.00 N/A
Income Taxes Paid Refund Classified As Operating Activities 16,569,000.00 N/A 21,492,000.00 27,634,000.00 N/A 51,619,000.00 57,749,000.00 N/A
Cash Flows From Used In Operating Activities 107,901,000.00 N/A 67,050,000.00 176,860,000.00 N/A 48,247,000.00 154,146,000.00 N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A N/A 38,000.00 0.00 N/A N/A 0.00 N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities 11,249,000.00 N/A 33,220,000.00 39,101,000.00 N/A 13,691,000.00 21,181,000.00 N/A
Purchase Of Intangible Assets Classified As Investing Activities 13,373,000.00 N/A 8,342,000.00 16,815,000.00 N/A 10,313,000.00 19,635,000.00 N/A
Cash Flows From Used In Investing Activities -24,683,000.00 N/A -41,650,000.00 -56,046,000.00 N/A -24,023,000.00 -40,831,000.00 N/A
Proceeds From Borrowings Classified As Financing Activities 168,000.00 N/A 121,000.00 433,000.00 N/A -84,000.00 -14,000.00 N/A
Payments Of Lease Liabilities Classified As Financing Activities 854,000.00 N/A 854,000.00 1,729,000.00 N/A 1,393,000.00 2,844,000.00 N/A
Dividends Paid Classified As Financing Activities 26,104,000.00 N/A 69,610,000.00 69,610,000.00 N/A N/A 0.00 N/A
Other Inflows Outflows Of Cash Classified As Financing Activities N/A N/A N/A 1,895,000.00 N/A N/A -67,000.00 N/A
Cash Flows From Used In Financing Activities -26,037,000.00 N/A -66,191,000.00 -69,012,000.00 N/A -1,478,000.00 -2,925,000.00 N/A
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 57,181,000.00 N/A -40,791,000.00 51,802,000.00 N/A 20,253,000.00 110,390,000.00 N/A
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -4,013,000.00 N/A 5,414,000.00 7,114,000.00 N/A -4,856,000.00 -2,844,000.00 N/A
Cash and cash equivalents 150,109,000.00 96,941,000.00 114,732,000.00 209,025,000.00 150,109,000.00 224,422,000.00 316,571,000.00 209,025,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
DAN
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
DAN
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DK0060055861

LEI

213800533NBKECGONO68

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Nasdaq Copenhagen

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.